Zoledronic acid plus methylprednisolone <i>versus</i> zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial.

Ther Adv Musculoskelet Dis · 2019 · PMC6811759 · PMID 31692649

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared with placebo, VOLT01 but not ZA improved knee function and showed a trend toward improving knee pain after 6 months.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.